Replimune Group, Inc. (REPL) Earnings Per Share (EPS)
Replimune Group, Inc. (REPL) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2019-03-31 | N/A |
| 2020-03-31 | -$1.54 |
| 2021-03-31 | -$1.75 |
| 2022-03-31 | -$2.26 |
| 2023-03-31 | -$2.99 |
| 2024-03-31 | -$3.24 |
| 2025-03-31 | -$3.07 |
| 2026-03-31 | -$3.38 |
How REPL compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| VSTM | Verastem Inc. | -$3.02 |
| EYPT | EyePoint Pharmaceuticals Inc. | -$3.17 |
| KURA | Kura Oncology Inc. | -$3.18 |
| SNDX | Syndax Pharmaceuticals Inc. | -$3.29 |
| VNDA | Vanda Pharmaceuticals Inc. | -$3.74 |
These are five companies in the same sector as REPL with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Replimune Group, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("REPL")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | REPL | $13.85 | +1.32% | 2.85M |
| 3 | ||||
| 4 | ||||
| 5 |